Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy-Reference-Cited by-同舟云学术

Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy

Published:2018-08 Issue:4 Volume:1 Page:294-302
ISSN:2573-1599
Container-title:The CRISPR Journal
language:en
Short-container-title:The CRISPR Journal

Author:

Link Robert W.¹,Nonnemacher Michael R.²³⁴⁵,Wigdahl Brian²³⁴⁵,Dampier Will¹²³

Affiliation:

1. School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania

2. Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania

3. Center for Molecular Virology and Translational Neuroscience, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania

4. Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

5. Center for Genomic Sciences, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, Pennsylvania

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Biotechnology

Link

http://www.liebertpub.com/doi/pdf/10.1089/crispr.2018.0020

Reference54 articles.

1. Integrase and integration: biochemical activities of HIV-1 integrase

2. Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners

3. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.

4. HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs

5. Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity;Molecular Therapy - Nucleic Acids;2024-06

2. Delivering CRISPR to the HIV-1 reservoirs;Frontiers in Microbiology;2024-05-15

3. Targeting HIV-1 with CRISPR/Cas9 delivered by retargeted adenoviruses effectively suppresses viral replication;2023-12-18

4. Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus;Journal of General Virology;2022-06-07

5. Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy;Methods in Molecular Biology;2022